Atlas Trials

Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

Clinical trial NCT04822883 · COMPLETED

Trial details

NCT number
NCT04822883
Sponsor
Recognify Life Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cognitive ImpairmentSchizophrenia
Start date
2021-04-26
Primary completion
2021-10-28
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.